Trial Profile
Phase I Study of Chemoradiation With Midostaurin (PKC412) For Locally Advanced Rectal Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Midostaurin (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions
- 11 Dec 2018 Status changed from active, no longer recruiting to completed.
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 20 Jun 2017 Planned End Date changed from 1 Jun 2022 to 1 Mar 2022.